|
1
|
Damber JE and Aus G: Prostate cancer.
Lancet. 371:1710–1721. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Grönberg H: Prostate cancer epidemiology.
Lancet. 361:1048–1053. 2003. View Article : Google Scholar
|
|
3
|
Scher HI, Buchanan G, Gerald W, et al:
Targeting the androgen receptor: Improving outcomes for
castration-resistant prostate cancer. Endocr Relat Cancer.
11:459–476. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Oike Y and Tabata M: Angiopoietin-like
proteins. Circ J. 73:2192–2197. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dhanabal M, LaRochelle WJ, Jeffers M,
Herrmann J, et al: Angioarretin: an antiangiogenic protein with
tumor-inhibiting properties. Cancer Res. 62:3834–3841.
2002.PubMed/NCBI
|
|
6
|
Kubota Y, Oike Y, Satoh S, et al:
Cooperative interaction of Angiopoietin-like proteins 1 and 2 in
zebrafish vascular development. Proc Natl Acad Sci USA.
102:13502–13507. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Camenisch G, Pisabarro MT, Sherman D, et
al: ANGPTL3 stimulates endothelial cell adhesion and migration via
integrin alpha vbeta 3 and induces blood vessel formation in vivo.
J Biol Chem. 277:17281–17290. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ito Y, Oike Y, Yasunaga K, et al:
Inhibition of angiogenesis and vascular leakiness by
angiopoietin-related protein 4. Cancer Res. 63:6651–6657.
2003.PubMed/NCBI
|
|
9
|
Zeng L, Dai J, Ying K, et al:
Identification of a novel human angiopoietin-like gene expressed
mainly in heart. J Hum Genet. 48:159–162. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Oike Y, Yasunaga K, Ito Y, et al:
Angiopoietin-related growth factor (AGF) promotes epidermal
proliferation, remodeling and regeneration. Proc Natl Acad Sci USA.
100:9494–9499. 2003. View Article : Google Scholar
|
|
11
|
Katoh Y and Katoh M: Comparative
integromics on Angiopoietin family members. Int J Mol Med.
17:1145–1149. 2006.PubMed/NCBI
|
|
12
|
Aoi J, Endo M, Kadomatsu T, et al:
Angiopoietin-like protein 2 is an important facilitator of
inflammatory carcinogenesis and metastasis. Cancer Res.
71:7502–7512. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Endo M, Nakano M, Kadomatsu T, et al:
Tumor cell-derived angiopoietin-like protein ANGPTL2 is a critical
driver of metastasis. Cancer Res. 72:1784–1794. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tabata M, Kadomatsu T, Fukuhara S, et al:
Angiopoietin-like protein 2 promotes chronic adipose tissue
inflammation and obesity-related systemic insulin resistance. Cell
Metab. 10:178–188. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Okada T, Tsukano H, Endo M, et al:
Synoviocyte-derived angiopoietin-like protein 2 contributes to
synovial chronic inflammation in rheumatoid arthritis. Am J Pathol.
176:2309–2319. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Avraamidea CJ, Garmy-Susini B and Varner
JA: Integrins in angiogenesis and lymphangiogenesis. Nat Rev
Cancer. 8:604–617. 2008. View
Article : Google Scholar
|
|
17
|
Desgrosellier JS and Cheresh DA: Integrins
in cancer: biological implications and therapeutic opportunities.
Nat Rev Cancer. 10:9–22. 2010. View
Article : Google Scholar
|
|
18
|
Kikuchi R, Tsuda H, Kozaki K, et al:
Frequent inactivation of a putative tumor suppressor,
angiopoietin-like protein2, in ovarian cancer. Cancer Res.
68:5067–5075. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Saraon P and Jarvi K: Molecular
alterations during progression of prostate cancer to androgen
independence. Clin Chem. 57:1366–1375. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Schröder FH: Progress in understanding
androgen-independent prostate cancer (AIPC): a review of potential
endocrine-mediated mechanisms. Eur Urol. 53:1129–1173. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Aoi J, Endo M, Kadomatsu T, et al:
Angiopoietin-like protein 2 accelerates carcinogenesis by
activating chronic inflammation and oxidative stress. Mol Cancer
Res. 12:239–249. 2014. View Article : Google Scholar
|
|
22
|
Endo M, Yamamoto Y, Masuda T, et al: Serum
ANGPTL2 levels reflect clinical features of breast cancer patients:
implications for the pathogenesis of breast cancer metastasis. Int
J Biol Markers. 29:239–245. 2014.
|
|
23
|
Odagiri H, Kadomatsu T, Endo M, et al: The
secreted protein ANGPTL2 promotes metastasis of osteosarcoma cells
through integrin α5β1, p38 MAPK and matrix metalloproteinases. Sci
Signal. 7:ra72014. View Article : Google Scholar
|
|
24
|
Kuo TC, Tan CT, Chang YW, et al:
Angiopoetin-like protein 1 suppresses SLUG to inhibit cancer cell
motility. J Clin Invest. 123:1082–1095. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tan MJ, Teo Z, Sng MK, et al: Emerging
Roles of Angiopoietin-like 4 in human cancer. Mol Cancer Res.
10:677–688. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li H, Ge C, Zhao F, et al:
Hypoxia-inducible factor 1 alpha-activated angiopoietin-like
protein 4 contributes to tumor metastasis via vascular cell
adhesion molecule-1/integrin β1 signaling in human hepatocellular
carcinoma. Hepatology. 54:910–919. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Okochi-Takada E, Hattori N, Tsukamoto T,
et al: ANGPTL4 is a secreted tumor suppressor that inhibits
angiogenesis. Oncogene. 24:2273–2278. 2014. View Article : Google Scholar
|
